Hay, he's still waiting for the SEC to finish "flyspecking" the Moskowitz draft 10-K for 2009 and for the SEC to approve it so SPNGQ can file it, resume trading, and squeeze the imaginary 'naked shorts' in the MOASS. Then combine the SPNGQ IP with that of IPIX, HGENQ, GBLX, NVAX, and Sanofi for mAB-infused sponges and merge the 6-way CONglomerate into Taran in Australia.
This is how he bleeves IPIX baggholders will make bank.
Then, of course, the Taran superCONglomerate will buy NVDA for cash (loose change from the massive sales of placebos that produce the placebo effect for any and all diseases and CONditions), and STEVEN MOSKOWITZ will be the new nVidia CFO.
Voila (or "wah-lah" for iHub pennyvestors)!
A quiet/quite/quit straightforward binniss plann from the center of uber-savvy biotech investing: West Bumblefuck, Texass. Sand Hill Road has been relocated to Farm-to-Market Road #sevenhunnertansum where the top biotech VC hang their 8.125 gallon hats.
IPIX is only one component, one bolt, in the complex CONglomeration fantasy that originates with the nut behind the keyboard.
Even MARTIN SHKRELI didn't see this master plann. IPIX, SPNGQ, HGENQ, and GBLX baggholders are in the presence of greatness; the WARREN BUFFETT of biopharmaceutical investing and M&A.
A most amazing achievement for a dude who is incapable of interpreting and understanding a balance sheet and P/L financial statement (whether SEC "flyspecked" and approved or knott).
The last puzzle piece is BIOAQ. Jay needs to file for CONservatorship of that and be granted CONtrol before the remainder of the Bigg Plann can be executed. He must bring the long-suffering BIOAQ bleevers into the green as well as the IPIX, SPNGQ, HGENQ, and GBLX baggholders - then run the MOASS play.
Market Data 
Markets 
AI
